title: MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.
authors.forename: A
authors.initials: A
authors.lastname: Curioni-Fontecedro
authors.forename: A J
authors.initials: AJ
authors.lastname: Knights
authors.forename: M
authors.initials: M
authors.lastname: Tinguely
authors.forename: N
authors.initials: N
authors.lastname: Nuber
authors.forename: C
authors.initials: C
authors.lastname: Schneider
authors.forename: C W
authors.initials: CW
authors.lastname: Thomson
authors.forename: L
authors.initials: L
authors.lastname: von Boehmer
authors.forename: W
authors.initials: W
authors.lastname: Bossart
authors.forename: S
authors.initials: S
authors.lastname: Pahlich
authors.forename: H
authors.initials: H
authors.lastname: Gehring
authors.forename: H
authors.initials: H
authors.lastname: Moch
authors.forename: C
authors.initials: C
authors.lastname: Renner
authors.forename: A
authors.initials: A
authors.lastname: Knuth
authors.forename: A
authors.initials: A
authors.lastname: Zippelius
mesh_terms: D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000276:immunology*; D001483:Base Sequence; D015153:Blotting, Western; D017931:DNA Primers; D006801:Humans; D009101:Multiple Myeloma / Q000276:immunology*; D009363:Neoplasm Proteins / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm; C473332:CT7 antigen, human; D017931:DNA Primers; C110905:MAGEC1 protein, human; D009363:Neoplasm Proteins